Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | GLOW | Glutathione | NAD+ | KPV |
|---|---|---|---|---|
| Glutathione peroxidase / redox buffer (GSH system) | ||||
| Glutathione S-transferase / Phase II detoxification | ||||
| NAD+/NADH redox couple (sirtuins, PARPs, CD38) | ||||
| ROS / reactive oxygen species signaling | ||||
| AKT/mTOR/PPARγ signaling axis | ||||
| VEGFR2 / angiogenesis pathway (BPC-157) | ||||
| Actin-binding / cytoskeletal remodeling (TB-500/thymosin beta-4) | ||||
| Extracellular matrix / collagen synthesis (GHK-Cu) |
+1 more receptor
A structured, research-grounded protocol for this stack
Sign in to build a structured research protocol scaffold for GLOW + KPV + NAD+ + Glutathione — phases, per-compound parameters, endpoints and washout, grounded in documented research.
What VialTalk researchers actually run
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.